To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis

European Journal of Medical Genetics

Volumn 56, Issue 4, 2013, Pages 192-196

  Vernooij van Langen, Annette M M ^a,b   Reijntjens, Sandra ^a   Van der Pal, Sylvia M ^c   Loeber, J Gerard ^b   Dompeling, Edward ^d   Dankert Roelse, Jeannette E ^a  

^a Sittard Geleen Heerlen   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c TNO   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Carrier; Cystic fibrosis; DNA analysis; Focus group; Newborn screening

Indexed keywords

ACADEMIC ACHIEVEMENT; ARTICLE; CYSTIC FIBROSIS; DNA DETERMINATION; FAMILY; FAMILY PLANNING; FEMALE; GENE MUTATION; HEALTH EDUCATION; HEALTH STATUS; HETEROZYGOTE; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MALE; MARRIAGE; NETHERLANDS; NEWBORN SCREENING; NONVERBAL COMMUNICATION; PARENT; PREGNANCY; PRENATAL SCREENING; QUESTIONNAIRE; SCREENING TEST;

ADULT; CYSTIC FIBROSIS; DISCLOSURE; FEMALE; GENETIC TESTING; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PARENTS;

EID: 84875900889     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2013.01.006     Document Type: Article

References (16)

1. Castellani C., Southern K.W., Brownlee K., Dankert Roelse J., Duff A., Farrell M., Mehta A., Munck A., Pollitt R., Sermet-Gaudelus I., Wilcken B., Ballmann M., Corbetta C., de Monestrol I., Farrell P., Feilcke M., Ferec C., Gartner S., Gaskin K., Hammermann J., Kashirskaya N., Loeber G., Macek M., Mehta G., Reiman A., Rizzotti P., Sammon A., Sands D., Smyth A., Sommerburg O., Torresani T., Travert G., Vernooij A., Elborn S. European best practice guidelines for cystic fibrosis neonatal screening. J. Cyst Fibros. 2009, 8:153-173.
2. Wilcken B. Newborn screening for cystic fibrosis: techniques and strategies. J. Inherit. Metab. Dis. 2007.
3. Farrell P.M., Kosorok M.R., Laxova A., Shen G., Koscik R.E., Bruns W.T., Splaingard M., Mischler E.H. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin cystic fibrosis neonatal screening study group. N. Engl. J. Med. 1997, 337:963-969.
4. Lagoe E., Labella S., Arnold G., Rowley P.T. Cystic fibrosis newborn screening: a pilot study to maximize carrier screening. Genet. Test. 2005, 9:255-260.
5. Wheeler P.G., Smith R., Dorkin H., Parad R.B., Comeau A.M., Bianchi D.W. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: two years' experience in one medical center. Genet. Med. 2001, 3:411-415.
6. Watson E.K., Mayall E.S., Lamb J., Chapple J., Williamson R. Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet 1992, 340:217-220.
7. Oliver S., Dezateux C., Kavanagh J., Lempert T., Stewart R. Disclosing to parents newborn carrier status identified by routine blood spot screening. Cochrane Database Syst. Rev. 2004, CD003859.
8. Merelle M.E., Scheffer H., De Jong D., Dankert-Roelse J.E. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis. Acta Paediatr. 2006, 95:1424-1428.
9. Peterson-Sweeney K. The use of focus groups in pediatric and adolescent research. J. Pediatr. Health Care 2005, 19:104-110.
10. R.A. Krueger, Analyzing and reporting focus groups results, 1998.
11. R.A. Krueger, M.A. Casey, Focus Groups, a practical guide for applied research, fourth ed, 2009.
12. Ciske D.J., Haavisto A., Laxova A., Rock L.Z., Farrell P.M. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics 2001, 107:699-705.
13. Parsons E.P., Bradley D.M. Psychosocial issues in newborn screening for cystic fibrosis. Paediatr. Respir. Rev. 2003, 4:285-292.
14. Kai J., Ulph F., Cullinan T., Qureshi N. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice. Health Technol. Assess. 2009, 13:1-82. (iii).
15. Parsons E.P., Clarke A.J., Bradley D.M. Implications of carrier identification in newborn screening for cystic fibrosis. Arch. Dis. Child. Fetal Neonatal. Ed. 2003, 88:F467-F471.
16. Campbell P.W., White T.B. Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes. J. Pediatr. 2005, 147:S2-S5.